CN Stock MarketDetailed Quotes

300111 Zhejiang Sunflower Great Health

Watchlist
  • 3.53
  • +0.01+0.28%
Market Closed Dec 20 15:00 CST
4.54BMarket Cap130.74P/E (TTM)

About Zhejiang Sunflower Great Health Company

The company was founded in 2005 and listed on the Shenzhen GEM in August 2010. The company is committed to investing in pharmaceuticals, health and high-tech industries. In the future, it will build a big health industry cluster for pharmaceutical innovation, medical devices and pharmaceutical services, and a high-tech industrial cluster in the direction of TMT to seize the opportunities of China's economic transformation. The company's vision is “Health carries dreams, and action achieves the future”. The company's main business focuses on the pharmaceutical field, mainly R&D, production and sales of anti-infective, cardiovascular, and digestive drugs. The leading products cover the fields of anti-infective drugs, cardiovascular drugs, digestive system drugs, etc.

Company Profile

Short Name-A向日葵
Symbol-A300111
Company NameZhejiang Sunflower Great Health Co., Ltd.
Listing DateAug 27, 2010
Issue Price16.80
Shares Offered51.00M share(s)
FoundedMar 21, 2005
Legal Representativeshaoqin wu
General Managerhuaxin shi
Secretarylan li
Accounting FirmLixin Certified Public Accountants (Special General Partnership)
Legal CounselShanghai AllBright Law Firm
Employees25
Phone0575-88919159
Office AddressSanjiang Road, Paojiang Industrial Zone, Shaoxing City, Zhejiang Province
Zip Code312071
Registered AddressSanjiang Road, Paojiang Industrial Zone, Shaoxing, Zhejiang
Fax0575-88919159
Emailmichelle.li@sunowe.com
Websitehttp://www.sunowe.com/
Business License330600400004037
BusinessGeneral projects: technical services, technology development, technical consultation, technology exchange, technology transfer, technology promotion; manufacture of basic chemical raw materials (manufacture of licensed chemicals such as hazardous chemicals); investment activities with own funds; production of class 1 medical devices; sales of class 2 medical devices; production of chemical products (excluding licensed chemical products); sales of chemical products (excluding licensed chemical products); biochemical product technology research and development (except for projects subject to approval according to law, independently carry out business activities with a business license). Permitted projects: pharmaceutical production; import and export of pharmaceuticals; import and export of goods; production of class II medical devices; production of class III medical devices (projects subject to approval according to law can only be carried out business activities after approval by relevant departments; specific business projects are subject to the approval results).

Company Executives

  • Name
  • Position
  • Salary
  • shaoqin wu
  • Chairman, Directors, Chairman of the Strategy Committee
  • --
  • feng wu
  • Directors, Audit Committee Member, Strategy Committee Member, Member of the Remuneration and Assessment Committee
  • --
  • huaxin shi
  • Directors, General Manager
  • 717.30K
  • weibiao pan
  • Directors, Deputy General Manager, Chief Financial Officer, Nomination Committee Members, Strategy Committee Member
  • 566.30K
  • dongzhe sun
  • Independent Directors, Nomination Committee Members, Audit Committee Member, Strategy Committee Member, Chairman of the Remuneration and Assessment Committee
  • 29.70K
  • qin zhu
  • Independent Directors, Chairman of the Nomination Committee
  • --
  • rongfang chen
  • Independent Directors, Chairman of the Audit Committee, Member of the Remuneration and Assessment Committee, Strategy Committee Member
  • --
  • lan li
  • Board Secretary
  • 413.10K
  • qiong wu
  • Chairman of the Supervisory Board, Auditors
  • --
  • ji zhu
  • Auditors
  • 150.30K
  • weijiang ping
  • Deputy General Manager
  • 515.60K
  • qidong han
  • Internal Audit Manager
  • --
  • xiujun wang
  • Employee Supervisors
  • 7.20K
Heat List
CN
Overall
Symbol
Price
% Chg

No Data